VN April 2026

Vetnews | April 2026 14 « BACK TO CONTENTS Background Ticks are globally recognised as important vectors of disease, capable of transmitting a broad spectrum of viral, bacterial, and protozoan pathogens to vertebrate hosts [1]. In Europe, Ixodes ricinus serves as the primary vector of tick-borne pathogens affecting both humans and animals [2, 3]. In Norway, this tick species is predominantly distributed along the coastal regions, ranging from Østfold county in the southeast up to Brønnøysund in Nordland County in the north [4-6]. Tick infestation in dogs has been well documented across Europe [3]. Although nymphal ticks are more abundant than adult ticks in the environment [7], studies indicate that the ticks removed from dogs are predominantly adults, most likely because the small size of juvenile tick stages allows them to remain undetected in the dogs’ fur [8]. This indicates that dogs are at a high risk of acquiring tick-borne infections. However, as canine tick-borne infections are not notifiable in Norway, the number of infected or clinically affected dogs remains unknown. Clinically relevant infections reported in dogs include those caused by viral agents such as tick-borne encephalitis virus (TBEV) and louping ill virus; bacterial pathogens within the Borreliae, Ehrlichiae/ Anaplasmae, and Rickettsiae families; and protozoan parasites such as Babesia spp., all of which contribute to the overall disease burden in endemic areas [9]. Among the most well-known tickborne pathogens affecting canines in northern Europe are Borrelia burgdorferi sensu lato (s. l.), TBEV, and Anaplasma phagocytophilum [3, 10-12]. Lyme borreliosis (LB), caused by B. burgdorferi s. l., is the most frequent tick-borne human disease in Europe, with an increasing impact on public health [13]. In Norway, the number of reported cases of systemic LB has doubled over the past decade, from 323 cases in 2014 to 643 cases in 2024 [14]. Although B. burgdorferi s. l. infects a variety of wild and domestic animals, the clinical outcomes vary depending on the animal species [3]. In dogs, infections are often mild and self-limiting, and the majority of seropositive individuals remain asymptomatic [12]. When clinical signs do occur, they may include intermittent lameness, joint pain, fever, and lymphadenopathy, and they can appear several months after tick exposure [12, 15, 16]. Tick-borne encephalitis (TBE) is an emerging zoonotic disease in Europe, posing a growing threat to both animal and human health. Although TBEV infection in dogs is primarily subclinical, clinical cases tend to be acute, severe, and frequently fatal [17]. Reported clinical signs include fever, behavioural changes, motor deficits, and multifocal neurological dysfunction [10, 17, 18]. Furthermore, it has been reported that the clinical presentations were consistent with inflammatory central nervous system disorders such as meningitis, meningoencephalitis, and meningomyelitis [10]. These findings underscore the significance of acknowledging the neurological effects of TBE infections in dogs. Tick-borne fever, caused by A. phagocytophilum, is regarded as the most prevalent tick-borne disease in domestic animals in Europe [19], and canine cases are reported worldwide [11]. A. phagocytophilum is an intracellular bacterium that primarily infects neutrophil granulocytes [20]. Although infection is common in endemic areas, the majority of dogs exposed to A. phagocytophilum appear to remain clinically healthy, as evidenced by widespread seropositivity despite a lack of documented clinical illness [11]. In dogs that develop clinical signs, infection is typically self-limiting and characterised by non-specific symptoms such as lethargy and fever, usually emerging after an incubation period of 1-2 weeks [21]. The most consistent laboratory finding is thrombocytopenia, which Article Antibodies against tick-borne pathogens in domestic dogs in Norway: Borrelia burgdorferi sensu lato, tick-borne encephalitis virus, and Anaplasma phagocytophilum Hanne Kloster1, Camilla Stormo1, Anita Haug Haaland2, Wenche Okstad3, Åshild Kristine Andreassen4,5, Snorre Stuen3, and Vivian Kjelland1* 1University of Agder, Faculty of Engineering Science, Department of Natural Sciences, Gimlemoen 25, NO-4630 Kristiansand, Norway 2Faculty of Veterinary Medicine, Department of Companion Animal Clinical Sciences, Norwegian University of Life Sciences, Elizabeth Stephansens vei 15, NO-1430 Ås, Norway 3Norwegian University of Life Sciences, Department of Production Animal Clinical Sciences, Section of Small Ruminant Research and Herd Health, Svebastadveien 112, NO-4325 Sandnes, Norway 4Norwegian Institute of Public Health, Division for Infection Control and Environmental Health, Department of Virology, P. O. Box 4404 Nydalen, NO-0403 Oslo, Norway 5University College of Southeast Norway, Department of Natural Sciences and Environmental Health, Gullbringveien 38, NO-3800 Boe, Norway Please note that this is an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note that there may be errors present which affect the content, and all legal disclaimers apply.

RkJQdWJsaXNoZXIy OTc5MDU=